World's Best Scientists 2026 revealed!
Award Badge
Medicine
Germany
2026

D-Index & Metrics

Medicine

D-Index
148
Citations
119556
World Ranking
1218
National Ranking
62

Research.com Recognitions

  • 2026 - Research.com Medicine in Germany Leader Award
  • 2023 - Research.com Medicine in Germany Leader Award

Overview

Guido Reifenberger is affiliated with Heinrich Heine University Düsseldorf in Germany. Their research primarily focuses on the fields of Medicine as well as Biochemistry, Genetics and Molecular Biology. Within these broad areas, their work extensively covers subfields such as Genetics, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, and Neurology.

Their scholarly contributions address major topics including Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Neuroblastoma Research and Treatments, Meningioma and Schwannoma Management, Epigenetics and DNA Methylation, Radiomics and Machine Learning in Medical Imaging, and Cancer Genomics and Diagnostics.

Reifenberger has published numerous papers in several prominent venues. Frequent publication sources include Neuro-Oncology, bioRxiv (Cold Spring Harbor Laboratory), Acta Neuropathologica, Neuropathology and Applied Neurobiology, and the Journal of Clinical Oncology.

Among their recent significant publications are:

  • The 2021 WHO Classification of Tumors of the Central Nervous System: a summary (2021, Neuro-Oncology)
  • EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood (2020, Nature Reviews Clinical Oncology)
  • cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading (2020, Brain Pathology)
  • cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas (2020, Acta Neuropathologica)
  • Glioma (2024, Nature Reviews Disease Primers)

Reifenberger has worked closely with a number of frequent coauthors, highlighting collaborative efforts in the field. These coauthors include Michael Weller, Andreas von Deimling, Jörg Felsberg, Wolfgang Wick, and Marc Remke.

Best Publications

  • The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

    David N. Louis;Arie Perry;Guido Reifenberger;Andreas von Deimling

  • The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

    David N Louis;Arie Perry;Pieter Wesseling;Daniel J Brat

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • DNA methylation-based classification of central nervous system tumours

    David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt

  • The WHO Classification of Tumors of the Nervous System

    Paul Kleihues;David N. Louis;Bernd W. Scheithauer;Lucy B. Rorke

  • Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

    Jeremy Schwartzentruber;Andrey Korshunov;Xiao Yang Liu;David T.W. Jones

  • International network of cancer genome projects

    Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker

  • Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

    Dominik Sturm;Hendrik Witt;Hendrik Witt;Volker Hovestadt;Dong Anh Khuong-Quang

  • The landscape of genomic alterations across childhood cancers

    Susanne N. Gröbner;Barbara C. Worst;Joachim Weischenfeldt;Joachim Weischenfeldt;Ivo Buchhalter

  • Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

    Genevieve Schindler;David Capper;David Capper;Jochen Meyer;Wibke Janzarik

  • Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

    Christian Hartmann;Christian Hartmann;Jochen Meyer;Jörg Balss;David Capper

  • Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

    Wolfgang Wick;Michael Platten;Christoph Meisner;Joerg Felsberg

  • EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.

    Michael Weller;Martin van den Bent;Matthias Preusser;Emilie Le Rhun

  • Long-term survival with glioblastoma multiforme

    Dietmar Krex;Barbara Klink;Christian Hartmann;Andreas Von Deimling

  • Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: Implications for classification of gliomas

    Christian Hartmann;Christian Hartmann;Bettina Hentschel;Wolfgang Wick;Wolfgang Wick;David Capper

  • European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas

    Michael Weller;Martin van den Bent;Jörg C Tonn;Roger Stupp

  • New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

    Dominik Sturm;Dominik Sturm;Brent A. Orr;Umut H. Toprak;Volker Hovestadt

  • NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide

    Wolfgang Wick;Christian Hartmann;Corinna Engel;Mandy Stoffels

  • Dissecting the genomic complexity underlying medulloblastoma

    David T. W. Jones;Natalie Jäger;Marcel Kool;Thomas Zichner

  • MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

    Michael Weller;Roger Stupp;Guido Reifenberger;Alba A. Brandes

Frequent Co-Authors

Michael Weller
Michael Weller University of Zurich
Andreas von Deimling
Andreas von Deimling Heidelberg University
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Wolfgang Wick
Wolfgang Wick German Cancer Research Center
Peter Lichter
Peter Lichter German Cancer Research Center
Torsten Pietsch
Torsten Pietsch University of Bonn
Andrey Korshunov
Andrey Korshunov German Cancer Research Center
Manfred Westphal
Manfred Westphal Universität Hamburg
David T. W. Jones
David T. W. Jones German Cancer Research Center
David Capper
David Capper Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA isn't limited to the traditional MD path. Prospective students can build healthcare careers through a variety of flexible, online options. For those interested in pharmaceuticals, pursuing a pharmacy school online accredited could lead to roles in clinical, retail, or research settings.

If you’re drawn to healthcare management and technology, an online mhi (Master’s in Health Information) prepares you for leadership positions managing medical data and patient information systems.

Other in-demand specialties include medical billing and coding. Earning a medical billing and coding certification online can quickly open up opportunities to work in hospitals, clinics, or as a remote professional.

Nursing remains a stable and rewarding pathway. Accelerating your career is possible with affordable, flexible education via some of the cheapest np programs online. These programs empower nurses to take on advanced practice roles and fill critical gaps in healthcare delivery.

Best Scientists Citing Guido Reifenberger

Trending Scientists

Recently Published Articles